IRIS
BURLANDO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.430
AS - Asia 86
SA - Sud America 29
NA - Nord America 6
Totale 7.551
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.429
CN - Cina 70
BR - Brasile 27
VN - Vietnam 13
US - Stati Uniti d'America 6
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
PK - Pakistan 1
SG - Singapore 1
Totale 7.551
Salva come PNG Salva come JPEG
Città #
Genova 3.014
Genoa 2.951
Vado Ligure 775
Rapallo 662
Beijing 33
Bordighera 26
Ashburn 6
Hanoi 3
Ho Chi Minh City 2
Osasco 2
São Luís 2
São Paulo 2
Amparo 1
Belo Horizonte 1
Biên Hòa 1
Buritama 1
Bắc Ninh 1
Cabo Frio 1
Castro 1
Curitiba 1
Da Nang 1
Farroupilha 1
Ferraz de Vasconcelos 1
Ha Long 1
Haiphong 1
Hortolândia 1
Imperatriz 1
Innsbruck 1
Itabaiana 1
Japeri 1
Muzaffargarh 1
Paulínia 1
Pindamonhangaba 1
Praia Grande 1
Resistencia 1
Ribeirão Preto 1
Rio Bonito 1
San Vicente de Tagua Tagua 1
Santana de Parnaíba 1
Santo André 1
Singapore 1
Taboão da Serra 1
Thái Bình 1
Vinh 1
Água Azul do Norte 1
Totale 7.511
Salva come PNG Salva come JPEG
Nome #
Le cheratosi attiniche nei pazienti con trombocitemia in trattamento con idrossiurea; L'esperienza della clinica dermatologica nella gestione dei farmaci biologici nella psoriasi moderata grave; Angiosarcoma della mammella. 328
TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis 170
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 169
Adverse effects of biological agents in the treatment of psoriasis. 167
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets 158
Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects 153
Bilateral Warthin tumor in psoriatic patients in therapy with multiple immunosuppressive therapy 148
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare Registry 135
Different Responses to Ustekinumab of Two HLA-Cw6-positive Homozygous Twins with Psoriasis 130
Atopic-like dermatitis after secukinumab injection: A case report 127
Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseases
 124
Pruritus characteristics in a large Italian cohort of psoriatic patients 122
PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study 118
Essential Thrombocythemia: The Dermatologic Point of View 116
Psoriasis as a cardiovascular risk factor: Updates and algorithmic approach 115
Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment 113
Narrow-band imaging: a useful tool for early recognition of oral lichen planus malignant transformation? 112
Un cas de cryptococcose cutanèe primitive sans diffusion systemique chez un patient immunodeprimé 108
Papular elastolytic giant cell granuloma: report of a case associated with monoclonal gammopathy and responsive to topical tacrolimus. 106
The management of Autoimmune diseases in preconception, pregnancy and lactation 102
Biological therapy in genital psoriasis in women 101
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement 100
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry 98
Primary cutaneous melanoma: Correlation between clinical and histologic aspects in a retrospective Italian study 98
An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient 94
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 94
Comedonal variant of chronic cutaneous lupus erythematosus causing mutilation of the earlobe 93
Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: A relevant class-effect 92
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 91
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 90
Ciprofloxacin as a Trigger for Bullous Pemphigoid: The Second Case in the Literature 90
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis 89
Role of high-resolution ultrasound in the evaluation of psoriatic onychopathy 87
Could Terra firma-forme dermatosis induce eczematous halo dermatitis? An hypothesis 87
Atypical and Rare Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the Best Management of Patients 86
Ashy dermatosis-like hyperpigmentation: not always the omeprazole's fault 85
Acetazolamide: a new trigger for bullous pemphigoid? 85
Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience 84
Cutaneous manifestations of HAV, HBV, HCV 82
A purplish plaque and multiple nodules on the arm 81
Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department 80
Detection of antibodies to anti-TNF agents in psoriatic patients: a preliminary study. 79
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 79
Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis 78
Vasculitis associated with connective tissue diseases 77
Acute urticarial rash after covid-19 vaccination containing polysorbate 80 77
Usefulness of Dermoscopy in Eruptive Syringomas in an Elderly Woman 75
A survey of psoriasis patients on biologics during COVID-19: a single centre experience 74
Can Methotrexate be a successful treatment for unresponsive generalized annular elastolytic giant cell granuloma? Case report and review of the literature 74
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study 73
The quality of life in Italian psoriatic patients treated with biological drugs. 72
Cutaneous effects of antihypertensive drugs 71
"De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature 70
The STRIPP questionnaire (Screening Tool for Rheumatologic Investigation in Psoriatic Patients) as a new tool for the diagnosis of early psoriatic arthritis 70
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 70
Serial biologic therapies in psoriasis patients: A 12-year, single-center, retrospective observational study 68
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis 65
COVID-19 “second wave” and vaccines: the dermatologists’ perspective 65
Effects of TNF-α inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study 63
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care 63
Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report 63
Considerations on inhibition of IL-23 in psoriatic women of childbearing potential 63
Study of efficacy and safety of rucinol and sophora alpha in the topical treatment of cutaneous hypermelanoses 62
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care 62
Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature 61
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation 60
Increased serum level of N-terminal Pro-B-type natriuretic peptide in psoriatic patients: a single-center study 57
Lichen planus flare following COVID-19 vaccination: A case report 56
The 30th birthday of chronic ulcerative stomatitis: A systematic review 54
Inflammatory/infectious cutaneous side effects of biological drugs in patients with psoriasis: a general review with personal data 54
Dermatoscopically narrowed surgical margins for head and neck basal cell carcinoma: A retrospective case-control study 52
Reticular Erythematous Mucinosis: Exclusive Involvement of the Axillary Region 52
Dermatoskopisch kontrollierte, schmalere Resektionsränder bei Basalzellkarzinomen an Kopf und Hals: Retrospektive Fallkontrollstudie 50
Differenti risposte a Ustekinumab in due gemelli omozigoti HLA-CW6 positivi affetti da psoriasi 50
Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report 49
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review 49
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients 46
Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection 46
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study 45
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 45
Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a 'perceived satisfaction': a multicentric study 43
null 43
Crushed corticosteroid tablets in peristomal pyoderma gangrenosum: A case report 41
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 40
Dimethyl fumarate-associated ashy dermatosis 39
Pruritic erythematous macules in a patient with systemic sarcoidosis: A quiz 38
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 34
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report 33
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS) 32
Psoriasis patients' characteristics associated with high PASI response to tildrakizumab: an international dual center study 30
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis) 28
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting 28
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study 27
Does psoriasis influence female sexual dysfunction? A multicentric Italian case-control study 25
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study 24
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing 24
Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centers 23
Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis 23
Linear atrophoderma of Moulin and atrophoderma of Pasini and Pierini. The relevance of ultrasound imaging in the initial assessment 18
Consensus on the place in therapy of biologics in the treatment of patients with chronic plaque psoriasis 16
Totale 7.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.483
article - articoli 34.207
book - libri 0
conference - conferenze 1.276
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 90 60 17 61 43 97 41 33
2021/2022856 34 29 28 74 35 117 12 184 85 109 24 125
2022/2023811 77 66 16 76 109 109 9 51 171 15 101 11
2023/2024901 33 75 37 102 67 147 56 118 18 59 110 79
2024/20251.989 70 136 47 136 260 199 169 323 65 99 204 281
2025/2026921 387 80 160 250 44 0 0 0 0 0 0 0
Totale 7.759